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PreviewsDuring the sustained DSS exposure, IL-18
affects the lamina propria and then the
deleterious effect of IL-18 dominates the
systems. During chronic DSS exposure,
there is enough time to recover, and the
caspase-12-meditated IEC proliferation
results in a sufficient regeneration that
becomes dangerous when the car-
cinogen enters the system. The working
model suggests that activation of Nlrp3
and IL-18 at the level of IEC is critical for
maintaining the intestinal homeostasis
and thus in the end the barrier against
bacterial translocation. In striking con-
trast, activation of Nlrp3 in the lamina
propria promotes intestinal inflammation.302 Immunity 32, March 26, 2010 ª2010 ElseREFERENCES
Dinarello, C.A. (2004). Immunity 20, 243–244.
Dupaul-Chicoine, J., Yeretssian, G., Doiron, K.,
Bergstrom, K.S.B., McIntire, C.R., LeBlanc, P.M.,
Meunier, C., Turbide, C., Gros, P., Beauchemin,
N., et al. (2010). Immunity 32, this issue, 367–378.
Kanai, T., Watanabe, M., Okazawa, A., Sato, T.,
Yamazaki, M., Okamoto, S., Ishii, H., Totsuka, T.,
Iiyama, R., Okamoto, R., et al. (2001). Gastroenter-
ology 121, 875–888.
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van
Loo, G., Danese, S., Huth, M., Nikolaev, A.,
Neufert, C., Madison, B., et al. (2007). Nature
446, 557–561.
Pizarro, T.T., Michie, M.H., Bentz, M., Worarata-
nadharm, J., Smith, M.F., Jr., Foley, E., Moskaluk,vier Inc.C.A., Bickston, S.J., and Cominelli, F. (1999).
J. Immunol. 162, 6829–6835.
Saitoh, T., Fujita, N., Jang, M.H., Uematsu, S.,
Yang, B.G., Satoh, T., Omori, H., Noda, T.,
Yamamoto, N., Komatsu, M., et al. (2008). Nature
456, 264–268.
Siegmund, B., Lehr, H.A., Fantuzzi, G., and
Dinarello, C.A. (2001). Proc. Natl. Acad. Sci. USA
98, 13249–13254.
Villani, A.C., Lemire, M., Fortin, G., Louis, E.,
Silverberg, M.S., Collette, C., Baba, N., Libioulle,
C., Belaiche, J., Bitton, A., et al. (2009). Nat. Genet.
41, 71–76.
Zaki, M.H., Boyd, K.L., Vogel, P., Kastan, M.B.,
Lamkanfi, M., and Kanneganti, T.-D. (2010).
Immunity 32, this issue, 379–391.Act1, Scene Brain: Astrocytes Play a Lead RoleJane M. Rodgers,1 Liang Zhou,1,2 and Stephen D. Miller1,*
1Department of Microbiology-Immunology
2Department of Pathology and The Interdepartmental Immunobiology Center
Feinberg School of Medicine, Northwestern University, 303 E. Chicago Avenue, Chicago, IL 60611, USA
*Correspondence: s-d-miller@northwestern.edu
DOI 10.1016/j.immuni.2010.03.009
Interleukin-17 (IL-17) is crucial for the progression of experimental autoimmune encephalomyelitis. In this
issue of Immunity, Kang et al. (2010) report that neuroectoderm-derived astrocytes are the critical cellular
element that responds to IL-17.Act1 is a crucial adaptor protein in the
interleukin-17 receptor (IL-17R) signaling
complex. Upon IL-17 binding, the hetero-
meric transmembrane receptor (IL-17RA
and IL-17RC) recruits and interacts with
Act1 by its SERIF domains (Chang et al.,
2006). A variety of cells express the
IL-17R signaling complex, facilitating
inflammatory responses to locally pro-
duced IL-17 in most tissues (Gaffen,
2009). IL-17-responsive cells are capable
of expanding local tissue inflammation
because IL-17 induces Act1-dependent
upregulation and mRNA stabilization of
proinflammatory cytokines and CXC
chemokines (Hartupee et al., 2007).
Several inflammatory autoimmune
disease models including experimental
autoimmune encephalomyelitis (EAE), a
mouse model of multiple sclerosis (MS),
have been shown to be mediated to a
substantial extent by Th17 cells, althoughboth Th1 and Th17 cells are capable of
inducing EAE individually, but probably
by different mechanisms and with dif-
ferent efficiency (Qian et al., 2007). As
previously reported (Qian et al., 2007),
mice deficient in Act1 exhibited delayed
onset and less severe myelin oligoden-
drocyte glycoprotein (MOG) peptide-in-
duced EAE. Given that there are multiple
stages and cell types involved in EAE
pathology, it was unclear at which stage
of disease pathogenesis IL-17, signaling
via Act1, was necessary, and it is this
question that was approached by Kang
et al. (2010) in this issue of Immunity.
EAE is a multistep inflammatory pro-
cess initiated by Th1 and Th17 cells. Dur-
ing actively induced EAE, myelin-specific
Th1 or Th17 cells are activated and ex-
pand in the peripheral lymphoid tissues
in response to myelin peptide and com-
plete Freund’s adjuvant (CFA) immuniza-tion. These activated T cells extravasate
across the blood brain barrier (BBB) sec-
ondary to interaction of very late activa-
tion antigen 4 (VLA-4) expressed on acti-
vated T cells with vascular cell adhesion
molecule (VCAM) expressed on cere-
brovascular endothelial cells (Yednock
et al., 1992). In the central nervous system
(CNS), infiltrating myelin-specific T cells
must be reactivated by brain-resident
antigen-presenting cells (including micro-
glia, macrophages, and myeloid dendritic
cells) presenting myelin antigen (Bailey
et al., 2007; Tompkins et al., 2002).
Release of Th1 or Th17 cell cytokines
induced by this interaction results in local
inflammation and demyelination of white
matter tracts, reducing the ability of axons
to conduct electrical signals and eventu-
ally neuronal transection. Astrocytes are
involved in nearly all processes within
the brain, but their contribution to EAE
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Figure 1. IL-17-Stimulated, Act1-Dependent Stimulation of CNS Astrocytes Is Required for
Progression of EAE via Chemokine-Mediated Recruitment of Peripheral Inflammatory Cells
Kang et al. (2010) suggest a necessary role for astrocytes in EAE pathology. After activatedmyelin-specific
Th17 cells infiltrate the CNS and are restimulated to produce IL-17, astrocytes that respond via expression
of IL-17R are stimulated to produce leukocyte-attracting chemokines in an Act1-dependent manner.
Astrocyte-derived chemokines then recruit a secondwave of peripheral inflammatory cells, whichmediate
EAE progression via Th17 cell-mediated bystander demyelination.
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Previewspathogenesis is not certain. In vitro stud-
ies suggest that they produce cytokines
that affect inflammatory cytokine produc-
tion by T cells as well as chemokines
that may attract additional peripheral
inflammatory leukocytes.
EAE can also be induced in mice by
adoptive transfer of myelin-specific
T cells from primed mice to naive recipi-
ents. Kang et al. (2010) utilized adoptive
transfer EAE to determine the role of
Act1 in both Th1 and Th17 cell-mediated
EAE and to distinguish at which stage of
disease this crucial signaling adaptor
protein operates. It is shown that transfer
of activated myelin-specific Th1 cells into
either naive wild-type or Act1-deficient
mice resulted in a normal EAE disease
course. However, transfer of activated
myelin-specific Th17 cells induced dis-
ease in wild-type, but not Act1-deficient
mice, in part because of impaired CNS
infiltration of Th17 cells in Act1-deficient
mice. Thus, Act1 regulates only Th17
cell-mediated EAE.
Data presented in this paper also sug-
gest that Act1-deficient Th17 cells are
not defective, but perhaps even more
pathogenic in induction of disease when
adoptively transferred into wild-type
mice. Further supporting the conclusion
that there were no defects in T cell activa-
tion or differentiation in Act1-deficient
mice, it is shown that the kinetics of initial
CNS infiltration of Act1-deficient T cellswas normal and that these T cells dis-
played normal expression of proliferation
and survival factors in wild-type recipi-
ents. Together, these data clearly demon-
strate that Act1 is not necessary for
normal activation, peripheral expansion,
infiltration, or effector function of the initial
infiltrating set of T cells. Not surprisingly,
the authors demonstrated that mice in
which Act1 deficiency was restricted to
endothelial cells by breeding floxed Act1
mice with TIE2e-Cre mice were normally
susceptible to EAE, ruling out the possi-
bility of endothelial cells as amajor cellular
compartment dependent on Act1.
Microglia are F4/80+CD11blo CNS-resi-
dent cells of hematopoietic origin, which
may play a role in both local presentation
of myelin epitopes as well as in carrying
out the effector stages of demyelination.
In addition, large numbers of CD11bhi
peripherally derived macrophages and
myeloid DCs (CD11bhiCD11c+) are re-
cruited into the CNS during EAE patho-
genesis and play important roles in anti-
gen presentation and epitope spreading,
recruitment of inflammatory cells, and
effector demyelination (Bailey et al.,
2007). Thus, CD11b+ cells were a possible
cellular compartment that may be depen-
dent on Act1. However, it is also shown
that mice develop EAE in a normal fashion
when Act1 deficiency was targeted to
CD11b+ cells by breeding floxed Act1
mice with CD11b-Cre mice.Immunity 3Neurons, oligodendrocytes, and astro-
cytes are considered brain-resident cells
because they originate from a common
progenitor in the neuroectoderm during
development (Gilyarov, 2008). During
early development, neuroectodermal cells
express nestin (NES), an intermediate
filament. Kang et al. (2010) thus used
NES-Cre mice mated with floxed Act1
mice to target Act1 deficiency to neuroec-
toderm-derived brain resident cells. Sim-
ilar to Act1 null mice, these brain-resident
cell-specific Act1-deficient mice were
susceptible to EAE transferred with Th1
cells, but displayed a markedly delayed
EAE onset and severity upon active MOG
peptide immunization and after transfer
of Th17 cells. These mice also had a
reduced IL-17-induced gene profile in
the lumbar spinal cord, where lesions are
common during EAE. These data clearly
identify brain-resident cells as the key
IL-17-induced, Act1-dependent cellular
responders.
Based on the previously discussed
data, the authors hypothesized that
astrocytes may play a key role in EAE
pathogenesis by IL-17-induced, Act1-
dependent upregulation of chemokines
necessary for the recruitment of the sec-
ond wave of peripheral leukocyte infiltra-
tion during EAE pathogenesis (Figure 1).
In support of their hypothesis, they
stimulated primary astrocytes from
NesCreAct1 floxed mice and control
mice with the cytokines IL-17, IFN-g,
and TNF-a separately or in combination.
They describe chemokine profiles spe-
cific to stimulation with either IL-17 and
TNF-a (CXCL1, CXCL2, CCL20) or IFN-g
and TNF-a (CXCL9, CXCL10, CXCL11),
highlighting cytokine-specific responses
in CNS-resident astrocytes. However,
only IL-17+TNF-a synergistic responses
were decreased by the nestin-specific
deletion of Act1, supporting an astro-
cyte-specific Act1-dependent response
to IL-17.
In summary, Kang et al. (2010) have
identified astrocytes as a key CNS-resi-
dent cell responsive to IL-17-driven
signaling (Figure 1). Upon stimulation
with IL-17, astrocytes, at least in vitro,
appear to respond to IL-17 by recruiting
Act1 to the IL-17R followed by recruit-
ment of the TAK1 (a kinase) and TRAF6
(an E3 ubiquitin ligase), which mediate
NF-kB activation. The subsequent upre-
gulation of a variety of chemokine genes2, March 26, 2010 ª2010 Elsevier Inc. 303
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Previewsrequired to direct the second wave of
recruitment of peripheral inflammatory
cells characterizes the inflammatory de-
myelinating process in EAE and presum-
ably MS. Despite long recognition of
astrogliosis as a key feature of neuroin-
flammatory processes, the significance
of this study is that it is the first in vivo
evidence for a pathologic role of astro-
cytes in EAE pathogenesis. This study
should stimulate future experiments
focused on exploring the in vivo response
of astrocytes to IL-17 and other inflamma-
tory cytokines involved in neuroinflamma-
tory diseases and the role of these glial
cells in recruitment of peripheral inflam-
matory cells. Astrocytes may receive
signals from both Th1 (IFN-g) and Th17
(IL-17, etc.) cells resulting in upregulation
of distinct patterns of cytokines and/or
chemokines, ultimately contributing to304 Immunity 32, March 26, 2010 ª2010 Elsedistinct pathological patterns of inflam-
mation. It will also be interesting to
explore the response of tissue-resident
cells to IL-17 in other Th17 cell-dependent
disease models such as arthritis and
asthma. However, it is important to keep
in mind that targeting Act1 in astrocytes
may have limited therapeutic implications
in MS because ablation of Act1 has no
significant influence on Th1 cell-mediated
neuroinflammation and that Act1 is a neg-
ative regulator of B cells through CD40L
and BAFF signaling (Qian et al., 2004).
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